SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILES PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )/1
AtheroGenics, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
047439 10 4
--------------------------------------------------------------------------------
(CUSIP Number)
August 9, 2000
--------------------------------------------------------------------------------
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is Filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
-----------------
1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 047439 10 4 Page 2 of 11 Pages
--------------------------------------------------------------------------------
1) Name of Reporting Person Domain Partners
I.R.S. Identification III, L.P.
No. of Above Person
(Entities Only)
--------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
--------------------------------------------------------------------------------
Number of 5) Sole Voting 1,406,884 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon
With exercise of
warrants)
-----------------------------------------------------
6) Shared Voting
Power -0-
-----------------------------------------------------
7) Sole Disposi- 1,406,884 shares
tive Power of Common Stock
(including shares
issuable upon
exercise of
warrants)
-----------------------------------------------------
8) Shared Dis-
positive Power -0-
-----------------------------------------------------
9) Aggregate Amount Beneficially 1,406,884 shares
Owned by Each Reporting person of Common Stock
(including shares
issuable upon
exercise of
warrants)
--------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
CUSIP No. 047439 10 4 Page 3 of 11 Pages
--------------------------------------------------------------------------------
11) Percent of Class
Represented by 5.9%
Amount in Row (9)
--------------------------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 047439 10 4 Page 4 of 11 Pages
--------------------------------------------------------------------------------
1) Name of Reporting Person DP III Associates,
I.R.S. Identification L.P.
No. of Above Person
(Entities Only)
--------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
--------------------------------------------------------------------------------
Number of 5) Sole Voting 48,673 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon
With exercise of
warrants)
-----------------------------------------------------
6) Shared Voting
Power -0-
-----------------------------------------------------
7) Sole Disposi- 48,673 shares
tive Power of Common Stock
(including shares
issuable upon
exercise of
warrants)
-----------------------------------------------------
8) Shared Dis-
positive Power -0-
-----------------------------------------------------
9) Aggregate Amount Beneficially 48,673 shares
Owned by Each Reporting person of Common Stock
(including shares
issuable upon
exercise of
warrants)
--------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
CUSIP No. 047439 10 4 Page 5 of 11 Pages
--------------------------------------------------------------------------------
11) Percent of Class
Represented by 0.2%
Amount in Row (9)
--------------------------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 047439 10 4 Page 6 of 11 Pages
Schedule 13G
------------
Item 1(a) - Name of Issuer: AtheroGenics, Inc.
Item 1(b) - Address of Issuer's Principal Executive Offices:
8995 Westside Parkway
Alpharetta, GA 30004
Item 2(a) - Name of Person Filing:
This statement is being filed by Domain Partners III, L.P.,
a Delaware limited partnership ("Domain III") and DP III
Associates, L.P., a Delaware limited partnership ("DP III A")
(together, the "Reporting Persons").
Item 2(b) - Address of Principal Business Office:
One Palmer Square
Princeton, NJ 08542
Item 2(c) - Place of Organization:
Domain III: Delaware
DP III A: Delaware
Item 2(d) - Title of Class of Securities:
Common Stock
Item 2(e) - CUSIP Number: 047439 10 4
Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or
13d-2(b):
Not applicable.
CUSIP No. 047439 10 4 Page 7 of 11 Pages
Item 4 - Ownership.
(a) Amount Beneficially Owned:
Domain III: 1,406,884 shares of Common Stock
(including shares issuable upon exercise of
warrants)
DP III A: 48,673 shares of Common Stock (including
shares issuable upon exercise of warrants)
(b) Percent of Class:
Domain III: 5.9%
DP III A: 0.2%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
Domain III: 1,406,884 shares of Common Stock
(including shares issuable upon exercise of
warrants)
DP III A: 48,673 shares of Common Stock (including
shares issuable upon exercise of warrants)
(ii) shared power to vote or to direct the vote:
-0-
(iii) sole power to dispose or to direct the
disposition of:
Domain III: 1,406,884 shares of Common Stock
(including shares issuable upon exercise of
warrants)
DP III A: 48,673 shares of Common Stock (including
shares issuable upon exercise of warrants)
(iv) shared power to dispose or to direct the disposition of:
-0-
Item 5 - Ownership of Five Percent or Less of a Class:
Not applicable.
CUSIP No. 047439 10 4 Page 8 of 11 Pages
Item 6 - Ownership of More than Five Percent on Behalf of
Another Person:
Not applicable.
Item 7 - Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on by the Parent Company:
Not applicable.
Item 8 - Identification and Classification of Members of the Group:
See Exhibit 2.
Item 9 - Notice of Dissolution of Group:
Not applicable.
Item 10 - Certification:
Not applicable.
CUSIP No. 047439 10 4 Page 9 of 11 Pages
Signature:
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DOMAIN PARTNERS III, L.P.
By: One Palmer Square Associates
III, L.P., General Partner
By /s/ Kathleen K. Schoemaker
--------------------------------
General Partner
DP III ASSOCIATES, L.P.
By: One Palmer Square Associates
III, L.P., General Partner
By /s/ Kathleen K. Schoemaker
--------------------------------
General Partner
Date: February 9, 2001
CUSIP No. 047439 10 4 Page 10 of 11 Pages
EXHIBIT 1
AGREEMENT OF
DOMAIN PARTNERS III, L.P.
AND
DP III ASSOCIATES, L.P.
PURSUANT TO RULE 13d-1(f)
-------------------------
The undersigned hereby agree that the Information Statement on Schedule 13G
to which this Agreement is annexed as Exhibit 1 is filed on behalf of each of
them in accordance with the provisions of 13d-1(f) under the Securities Exchange
Act of 1934, as amended.
DOMAIN PARTNERS III, L.P.
By: One Palmer Square Associates
III, L.P., General Partner
By /s/ Kathleen K. Schoemaker
--------------------------------
General Partner
DP III ASSOCIATES, L.P.
By: One Palmer Square Associates
III, L.P., General Partner
By /s/ Kathleen K. Schoemaker
--------------------------------
General Partner
Date: February 9, 2001
CUSIP No. 047439 10 4 Page 11 of 11 Pages
EXHIBIT 2
Identification and Classification
of Members of the Group
-----------------------------------
Domain Partners III, L.P.and DP III Associates, L.P. are filing this
statement on Schedule 13G as a group.
Domain Partners III, L.P. is a Delaware limited partnership. Its sole
general partner is One Palmer Square Associates III, L.P., a Delaware limited
partnership.
DP III Associates, L.P. is a Delaware limited partnership. Its sole general
partner is One Palmer Square Associates III, L.P., a Delaware limited
partnership.